]>
IRCT20170919036285N2 IRCT 2019-03-18 Hamedan University of Medical Sciences Effect of low level laser therapy on post operative scar Evaluation the effect of low level laser therapy with 940 nm wavelength Diode laser on the reduction of post operative scar: a double blind prospective clinical trial study 2018-07-23 anticipated 14 Complete https://irct.ir/trial/35871 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Simple, before laser irradiation we will use a coin to decide the side of irradiation. If the numeric side appears, the right side will be irradiated and vise versa, Blinding description: In the present study the field of surgery in one side irradiated by laser but the other one receive placebo. The person who is responsible for irradiation is the only one who is aware about the side of placebo and laser irradiation. So patients, surgeon, nurses and assistants of surgery department, surgeon who assess the scar and statistical analyzer are not aware about placebo side. N/A scar. Intervention 1: Intervention group: in this group 940 nano meter diode laser, made by BIOASE company of the USA, is used. Irradiation is done on 4th and 8th day after surgery and then after 2 times a week for a month. Intervention 2: Control group: Laser machine in ready for use status, precisely similar to intervention group will be placed on incision place but no irradiation will be done. Yes - There is a plan to make this available What will be shared: All data could be shared When: it is reachable after article publication To whom: It is reachable for researchers. Conditions: According to the cases of other researchers will be decided Where to obtain: via the email address m.jazaeri@umsha.ac.ir How to obtain: 6 months after publication by sending email and defining the the cooperation protocol, after 2 weeks data is reachable Comments:
public Dr. mina jazaeri
Department of Oral Medicine, School of Dentistry, Shahid Fahmide Blvd., Hamadan, Iran.
Hamadan Iran (Islamic Republic of) 6515565687 +98 81 3838 1059 m.jazaeri@umsha.ac.ir Hamedan University of Medical Sciences scientific Dr. mina jazaeri
Department of Oral Medicine, School of Dentistry, Shahid Fahmide Blvd., Hamadan, Iran.
Hamadan Iran (Islamic Republic of) 6515565687 +98 81 3838 1059 m.jazaeri@umsha.ac.ir Hamedan University of Medical Sciences Iran (Islamic Republic of) Patients who sign informed consents form Those who are candidate for bilateral elective facial surgery no limit no limit Both patients with congenital and acquired dermal diseases Diabetes Phenytoin consumption Chemotherapy Radiotherapy Any other diseases which may affect wounds healing L90.5 Scar conditions and fibrosis of skin Treatment - Other Placebo Intervention group: in this group 940 nano meter diode laser, made by BIOASE company of the USA, is used. Irradiation is done on 4th and 8th day after surgery and then after 2 times a week for a month. Control group: Laser machine in ready for use status, precisely similar to intervention group will be placed on incision place but no irradiation will be done. Scar severity according to VAS. Timepoint: Scar evaluation 1 and 6 months after surgery. Method of measurement: VAS scor. Hamedan University of Medical Sciences Approved 2017-05-27 Ethics committee of Hamadan University of Medical Sciences Shahid Fahmideh Blvd, Hamadan University of Medical Sciences, Vice-Chancellor for Research and Technology, Ethics committe Hamadan Hamadan Iran (Islamic Republic of)